Peritoneal Tumor Pipeline Review, H2 2012 New Report
Peritoneal Tumor - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Peritoneal Tumor, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Peritoneal Tumor.
View full press release